Rosario Maselli

Author PubWeight™ 17.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The potential of biologics for the treatment of asthma. Nat Rev Drug Discov 2012 1.11
2 Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir Med 2008 1.07
3 Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 2005 1.07
4 Mitogen-activated protein kinases and asthma. J Cell Physiol 2005 1.04
5 Update on anticytokine treatment for asthma. Biomed Res Int 2013 0.92
6 Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol 2007 0.89
7 Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. Am J Respir Cell Mol Biol 2003 0.89
8 Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. J Cell Biochem 2005 0.88
9 Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. J Cell Biochem 2004 0.87
10 Respiratory infections and asthma. Respir Med 2005 0.86
11 Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. BMC Pharmacol Toxicol 2014 0.85
12 Update on optimal use of omalizumab in management of asthma. J Asthma Allergy 2011 0.83
13 Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Investig 2004 0.81
14 Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrronium. Pharmacology 2014 0.81
15 Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 2011 0.80
16 Omalizumab in the treatment of severe asthma: efficacy and current problems. Ther Adv Respir Dis 2008 0.79
17 Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells. Diagn Microbiol Infect Dis 2008 0.79
18 Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings. Clin Drug Investig 2013 0.77
19 Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment. Expert Opin Pharmacother 2015 0.75
20 Biological targets for therapeutic interventions in COPD: clinical potential. Int J Chron Obstruct Pulmon Dis 2006 0.75
21 Potential genetic influences on the response to asthma treatment. Pulm Pharmacol Ther 2004 0.75